Duke Industry Statistics Symposium 2019

 

Innovative Design and Analysis for Complex Clinical Trials for Drug and Device Developments

The Annual Duke Industry Statistics Symposium (DISS) is organized by the Department of Biostatistics and Bioinformatics, Duke University School of Medicine, and co-sponsored by Boehringer-Ingelheim, ICSA, Janssen, NC-ASA Chapter, Parexel, PPD, IQVIA and SAS. It was established 6 years ago to discuss challenging issues and recent advances related to the clinical development of drugs and devices and to promote research and collaboration among statisticians from industry, academia, and regulatory agencies.

The theme for symposium in Spring, 2019 was "Innovative Design and Analysis for Complex Clinical Trials for Drug and Device Developments.” The first day included four short courses. The 2nd day will began with a keynote by Dr. John Scott, Director for the Center for Biologics Evaluation and Research with the U.S. Food and Drug Administration on "Infoming Decision Making Through Innovative Trial Designs and Analysis" followed by parallel sessions.  On Friday morning , Dr. Scott Berry of Berry Consultants,LLC gave a keynote on "Innovating the Clinical Trial: Adaptive and Platform"  followed by the remainder of the parallel scientific sessions. A poster session was also held.  Click here to learn more.